Literature DB >> 24651942

Bladder dysfunction and hypertension in children with Guillain-Barre syndrome.

Louise Watson1, Majid Aziz, Grace Vassallo, Nicholas D Plant, Nicholas J A Webb.   

Abstract

BACKGROUND: Guillain-Barre syndrome (GBS) causes acute motor, sensory and autonomic dysfunction. There is a relative paucity of published data regarding the autonomic features of GBS. The aims of this study were to describe the incidence, management and outcome of bladder dysfunction and hypertension in GBS and to ascertain whether these features relate to muscle weakness severity. CASE-DIAGNOSIS/TREATMENT: Twenty-seven patients with a median (interquartile range) age of 5.7 (3.5-8.4) years were included, of whom 18 (67%) were male and 14 (52%) had autonomic dysfunction. One patient presented with and three subsequently developed urinary retention necessitating catheterisation for a median of 7.5 (7-14.5) days. Univariate analysis demonstrated that urinary retention was associated with weakness in all four limbs [retention: MRC muscle grade 2 (2-2.75); no retention: MRC grade 4 (3-4); p = 0.02], possibly reflecting more severe disease. Patients with hypertension (12 patients, 44%) had a longer hospital stay [median 32.5 (15.5-53.5) days; rho = 0.65; p = 0.02], and those with worse muscle weakness required more anti-hypertensive medications (upper limb rho = -0.71, p = 0.03; lower limb rho = -0.72, p = 0.03]. The majority of blood pressure treatments involved calcium channel and beta blockers.
CONCLUSION: In children with GBS, bladder dysfunction and hypertension are common. The presence of severe muscle weakness may predict those at greatest risk of these complications.

Entities:  

Mesh:

Year:  2014        PMID: 24651942     DOI: 10.1007/s00467-014-2799-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.

Authors:  K Ogawara; S Kuwabara; M Mori; T Hattori; M Koga; N Yuki
Journal:  Ann Neurol       Date:  2000-10       Impact factor: 10.422

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Guillain-Barré syndrome presenting with urinary retention and hypertension.

Authors:  Alexandra E Labovitz; Henry H Mangurten
Journal:  Clin Pediatr (Phila)       Date:  2004-09       Impact factor: 1.168

Review 4.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

5.  Concurrence of multiple sclerosis and inflammatory bowel disease.

Authors:  A D Sadovnick; D W Paty; G Yannakoulias
Journal:  N Engl J Med       Date:  1989-09-14       Impact factor: 91.245

Review 6.  Corticosteroids for Guillain-Barré syndrome.

Authors:  Richard Ac Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

7.  Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain-Barré syndrome.

Authors:  Nicholas S Abend; Carsten G Bonnemann; Daniel J Licht
Journal:  Pediatr Emerg Care       Date:  2007-09       Impact factor: 1.454

8.  Prevalence and correlates of blood pressure elevation in children with Guillain-Barré syndrome.

Authors:  W O Cooper; S R Daniels; J M Loggie
Journal:  Clin Pediatr (Phila)       Date:  1998-10       Impact factor: 1.168

9.  Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.

Authors:  H Rantala; J D Cherry; W D Shields; M Uhari
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

10.  Reversible left ventricular dysfunction associated with Guillain-Barré syndrome--an expression of catecholamine cardiotoxicity?

Authors:  K Iga; Y Himura; C Izumi; T Miyamoto; K Kijima; H Gen; T Konishi
Journal:  Jpn Circ J       Date:  1995-04
View more
  3 in total

1.  Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review.

Authors:  Yitao Zhang; Yanyin Zhao; Yi Wang
Journal:  Chin Neurosurg J       Date:  2018-06-18

2.  Yet Another Atypical Presentation of Anti-GQ1b Antibody Syndrome.

Authors:  Raed Alroughani; Anil Thussu; Raouf T Guindi
Journal:  Neurol Int       Date:  2015-09-24

3.  Posterior reversible encephalopathy as the first manifestation of Bickerstaff's brainstem encephalitis.

Authors:  Pei-Ru Chen; Shih-Pin Chen
Journal:  BMC Neurol       Date:  2016-11-08       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.